Dow Down 0.11% Nasdaq Up 0.09%

Neurocrine Biosciences, Inc. (NBIX)

-NasdaqGS
43.23 Dec 2, 4:00PM EST
|Pre-Market : 43.49 Up 0.26 (0.61%) 4:51PM EST - Nasdaq Real Time Price
Prev Close:43.23
Open:N/A
Bid:43.60 x 500
Ask:44.64 x 100
1y Target Est:68.00
Beta:0.652694
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:N/A - N/A
52wk Range:31.25 - 57.82
Volume:20
Avg Vol (3m):897,494
Market Cap:3.76B
P/E (ttm):N/A
EPS (ttm):-1.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBIX

Comparison

Symbol% ChgMkt Cap
NBIX 0.00%3.76B
LLY71.45B
PFE191.94B
ABT55.80B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):250.36
Ex-Dividend Date:29-Dec-95

Analysts

Annual EPS Est (Dec-16) :-1.68
Quarterly EPS Est (Dec-16) :-0.58
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.71

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback